Cannabis Drug Testing in Pro Sports — League-by-League (2026)
Side-by-side comparison of cannabis testing across the NFL, NBA, MLB, NHL, MLS, WNBA, NCAA, WADA, UFC, and state athletic commissions. Thresholds, windows, and penalties.
The 2026 Snapshot
Between December 2019 and June 2024, U.S. professional and collegiate sport quietly decoupled from anti-doping orthodoxy on cannabis. MLB removed natural cannabinoids from drugs of abuse on December 12, 2019. The NFL ended cannabis suspensions in March 2020 and softened penalties further in December 2024. The NBA's April 2023 collective-bargaining agreement removed marijuana from the Prohibited Substances List entirely on July 1, 2023. NCAA Division I removed cannabinoids from championship and postseason football testing on June 25, 2024. WADA, however, retains THC at 150 ng/mL on the in-competition Section S8 list under the 2026 Prohibited List (in force January 1, 2026), citing "spirit of sport" criteria.
The result is a fragmented rulebook in which a single athlete can simultaneously be governed by league CBA, state law, federal hemp law, WADA in-competition rules, and individual-school NCAA discretion. The table below is the side-by-side snapshot.
League-by-League Cannabis Testing Comparison
| Body | Tests for THC? | Threshold | Window | Penalty | Most Recent Reform |
|---|---|---|---|---|---|
| NFL Tested, fines only | Yes (PES policy) | 350 ng/mL (Dec 2024) | ~2-week training-camp window | Fines: $15K → $20K → game checks | Dec 6, 2024 NFL-NFLPA modification |
| NBA Removed from list | No | N/A | N/A | None for cannabis | July 1, 2023 CBA |
| MLB Removed from list | No (random) | N/A | N/A | Treatment-board referral; alcohol-equivalent | Dec 12, 2019 |
| MiLB Removed from list | No since 2020 | N/A | N/A | None | Dec 12, 2019 (parallel change) |
| NHL Tested, fines only | Yes (informational) | "Abnormally high" trigger | Year-round random | No automatic suspension; SABH referral only | Status quo since pre-2020 |
| MLS Prohibited in-competition | Yes | WADA standard (150 ng/mL) | In-competition | SABH-style program; CBA through 2027 | Feb 2021 CBA extension |
| NWSL Removed from list | No | N/A | N/A | None; CBD sponsorships allowed | 2022 CBA |
| WNBA Prohibited in-competition | Yes (limited) | Per CBA | In-season | Tiered fines for repeat offenses | 2020 CBA, 2025 negotiations |
| NCAA D-I Removed from list | No (postseason) | Schools may set in-season | Per-school discretion | Schools individually | June 25, 2024 |
| NCAA D-II / D-III Tested, fines only | Pending vote | 150 ng/mL until updated | Postseason testing | School discretion | Recommendation pending |
| WADA / IOC / Olympic Prohibited in-competition | Yes, in-competition | 150 ng/mL urine (raised from 15 in 2013) | In-competition only | Up to 2 yr suspension; Substance-of-Abuse provision allows reduction to 1 mo with rehab + non-performance use | 2026 Prohibited List (Jan 1, 2026) |
| USADA Prohibited in-competition | Yes (under WADA Code) | 150 ng/mL | In-competition | Per WADA Code | Substance-of-Abuse Article 10.2.4.1 since 2021 |
| UFC (CSAD era) Removed from list | Effectively no for cannabis | N/A absent "performance-enhancing" evidence | Year-round | None unless impairment proven | Jan 1, 2021 USADA change; 2024 CSAD transition |
| State Athletic Commissions | Vary | NSAC stopped punishing in 2021 | Per state | Per state | Florida May 2021; Nevada July 2021 |
Test Types and Science
Standard urine immunoassay screens for 11-nor-9-carboxy-Δ&sup9;-tetrahydrocannabinol (THC-COOH), the inactive metabolite that persists for days to weeks after exposure. Confirmatory testing uses GC-MS or LC-MS/MS. Hair testing extends the detection window to roughly 90 days. Saliva (oral fluid) detects parent THC and is sometimes proposed as a better proxy for current impairment — but no major league has adopted it for cannabis. Blood THC correlates poorly with impairment, per the U.S. Department of Transportation's July 2017 report to Congress.
The 150 ng/mL Threshold Backstory
WADA raised the urinary THC-COOH threshold from 15 to 150 ng/mL effective May 2013 to, in WADA Director of Communications Julie Masse's words, "focus on the athletes that abuse the substance in competition." The percentage of failed cannabis tests under WADA's program dropped from 9.0% in 2012 to 2.4% in 2014. A 180 ng/mL Decision Limit accounts for measurement uncertainty — a sample must exceed the Decision Limit, not just the threshold, to constitute an Adverse Analytical Finding. The NFL followed WADA to 150 ng/mL in March 2020 and pushed further to 350 ng/mL on December 6, 2024.
In-Competition vs Out-of-Competition
This distinction is the most-misunderstood concept in athlete cannabis policy. WADA defines the in-competition period as "commencing at 11:59 p.m. on the day before a Competition in which the Athlete is scheduled to participate, through to the end of that Competition and the Sample collection process" (2026 Prohibited List). Out-of-competition cannabis use is not a violation under the WADA Code — but the math of THC-COOH persistence means a heavy out-of-competition user can still cross the 150 ng/mL line on competition day. The same logic governs MLS in-competition testing and pre-2024 NCAA championship testing. See In-Competition vs Out-of-Competition and washout protocols for the practical implications.
How to Use This Section
The pages that follow walk through each testing body in detail: the NFL's training-camp window, the NBA's full removal and entrepreneurial allowances, the MLB-Charlotte's Web partnership, the NHL SABH framework, the soccer and women's pro picture, the NCAA chronology, the WADA in-competition ban, the UFC and Diaz cases, and the state athletic commissions. For test mechanics, see Drug Testing Overview.